Skip to main content
AFC-HD AMS Life Science Co.,Ltd. logo

AFC-HD AMS Life Science Co.,Ltd. — Investor Relations & Filings

Ticker · 2927 ISIN · JP3124700000 T Manufacturing
Open in API
Filings indexed 76 across all filing types
Latest filing 2026-05-11 Major Shareholding Noti…
Country JP Japan
Listing T 2927

About AFC-HD AMS Life Science Co.,Ltd.

http://www.ams-life.com/eng/

AFC-HD AMS Life Science Co., Ltd. is a comprehensive Original Equipment Manufacturer (OEM) specializing in the development, manufacturing, and sale of health foods, dietary supplements, and cosmetics. The company operates across both the healthcare and pharmaceutical business segments. Through its group subsidiaries, it manages a vertically integrated model encompassing research and development, GMP-certified production, and distribution channels such as mail-order sales and wholesale. Key activities include the R&D of innovative supplements through its preventive medical laboratory and the creation of health-related media content. The company delivers a wide spectrum of quality products to meet diverse customer needs.

Recent filings

Filing Released Lang Actions
変更報告書
Major Shareholding Notification Classification · 95% confidence The document is a Japanese “大量保有報告書” (Large Shareholding Report) filed under the Financial Instruments and Exchange Act to disclose a >1% change in an investor’s stake (Change Report No.4). It provides detailed share counts, percentages, legal basis, filing date, and issuer information. This matches our “Major Shareholding Notification” category (MRQ).
2026-05-11 Japanese
（開示内容の変更）連結子会社株式会社さいか屋の資本金および資本準備金の額の減少等の効力発生日の変更に関するお知らせ
Regulatory Filings
2026-04-15 Japanese
確認書
Regulatory Filings Classification · 82% confidence The document is a Japanese filing under the Financial Instruments and Exchange Act (金融商品取引法第24条の５の２第１項) titled “確認書,” confirming the appropriateness of the half‐year report (半期報告書) for the period September 1, 2025 to February 28, 2026. It is not the semiannual report itself (IR), nor an announcement of dividend, capital change, director transaction, or other specific category. It is a statutory confirmation statement, best classified under the generic Regulatory Filings category.
2026-04-14 Japanese
半期報告書－第46期(2025/09/01－2026/08/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Tokai Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and corporate information for the interim period ending February 28, 2026. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. H1 2026
2026-04-14 Japanese
通期連結業績予想の上方修正に関するお知らせ
Regulatory Filings
2026-04-14 Japanese
2026年8月期 第2四半期(中間期)決算短信〔日本基準〕（連結）
Regulatory Filings
2026-04-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.